| SCGB3A1 | |||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Aliases | SCGB3A1, HIN-1, HIN1, LU105, PnSP-2, UGRP2, secretoglobin family 3A member 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| External IDs | OMIM: 606500 MGI: 1915912 HomoloGene: 14160 GeneCards: SCGB3A1 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| Wikidata | |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Secretoglobin family 3A member 1 is a protein that in humans is encoded by the SCGB3A1 gene.[5][6]
References
- 1 2 3 GRCh38: Ensembl release 89: ENSG00000161055 - Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000064057 - Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, Kaelin CM, Rhei E, Bosenberg M, Schnitt S, Marks JR, Pagon Z, Belina D, Razumovic J, Polyak K (August 2001). "HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells". Proceedings of the National Academy of Sciences of the United States of America. 98 (17): 9796–801. Bibcode:2001PNAS...98.9796K. doi:10.1073/pnas.171138398. PMC 55532. PMID 11481438.
- ↑ "Entrez Gene: SCGB3A1 secretoglobin, family 3A, member 1".
Further reading
- Porter D, Lahti-Domenici J, Torres-Arzayus M, Chin L, Polyak K (June 2002). "Expression of high in normal-1 (HIN-1) and uteroglobin related protein-1 (UGRP-1) in adult and developing tissues". Mechanisms of Development. 114 (1–2): 201–4. doi:10.1016/S0925-4773(02)00056-4. PMID 12175512. S2CID 1770009.
- Reynolds SD, Reynolds PR, Pryhuber GS, Finder JD, Stripp BR (December 2002). "Secretoglobins SCGB3A1 and SCGB3A2 define secretory cell subsets in mouse and human airways". American Journal of Respiratory and Critical Care Medicine. 166 (11): 1498–509. doi:10.1164/rccm.200204-285OC. PMID 12406855.
- Niimi T, Copeland NG, Gilbert DJ, Jenkins NA, Srisodsai A, Zimonjic DB, Keck-Waggoner CL, Popescu NC, Kimura S (2003). "Cloning, expression, and chromosomal localization of the mouse gene (Scgb3a1, alias Ugrp2) that encodes a member of the novel uteroglobin-related protein gene family". Cytogenetic and Genome Research. 97 (1–2): 120–7. doi:10.1159/000064067. PMID 12438750. S2CID 37313915.
- Krop I, Maguire P, Lahti-Domenici J, Lodeiro G, Richardson A, Johannsdottir HK, Nevanlinna H, Borg A, Gelman R, Barkardottir RB, Lindblom A, Polyak K (May 2003). "Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors". Cancer Research. 63 (9): 2024–7. PMID 12727813.
- Bin LH, Nielson LD, Liu X, Mason RJ, Shu HB (July 2003). "Identification of uteroglobin-related protein 1 and macrophage scavenger receptor with collagenous structure as a lung-specific ligand-receptor pair". Journal of Immunology. 171 (2): 924–30. doi:10.4049/jimmunol.171.2.924. PMID 12847263.
- Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S, Argani P (December 2003). "DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma". International Journal of Cancer. 107 (6): 970–5. doi:10.1002/ijc.11508. PMID 14601057. S2CID 43639879.
- Tisserand P, Fouquet C, Barrois M, Gallou C, Dendale R, Stoppa-Lyonnet D, Sastre-Garau X, Fourquet A, Soussi T (2004). "Lack of HIN-1 methylation defines specific breast tumor subtypes including medullary carcinoma of the breast and BRCA1-linked tumors". Cancer Biology & Therapy. 2 (5): 559–63. doi:10.4161/cbt.2.5.511. PMID 14614327. S2CID 25141850.
- Marchetti A, Barassi F, Martella C, Chella A, Salvatore S, Castrataro A, Mucilli F, Sacco R, Buttitta F (February 2004). "Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome". Clinical Cancer Research. 10 (4): 1338–43. doi:10.1158/1078-0432.CCR-1174-03. PMID 14977834.
- Zhang Z, Henzel WJ (October 2004). "Signal peptide prediction based on analysis of experimentally verified cleavage sites". Protein Science. 13 (10): 2819–24. doi:10.1110/ps.04682504. PMC 2286551. PMID 15340161.
- Krop I, Player A, Tablante A, Taylor-Parker M, Lahti-Domenici J, Fukuoka J, Batra SK, Papadopoulos N, Richards WG, Sugarbaker DJ, Wright RL, Shim J, Stamey TA, Sellers WR, Loda M, Meyerson M, Hruban R, Jen J, Polyak K (September 2004). "Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types". Molecular Cancer Research. 2 (9): 489–94. doi:10.1158/1541-7786.489.2.9. PMID 15383627. S2CID 25730252.
- Shigematsu H, Suzuki M, Takahashi T, Miyajima K, Toyooka S, Shivapurkar N, Tomlinson GE, Mastrangelo D, Pass HI, Brambilla E, Sathyanarayana UG, Czerniak B, Fujisawa T, Shimizu N, Gazdar AF (February 2005). "Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies". International Journal of Cancer. 113 (4): 600–4. doi:10.1002/ijc.20622. PMID 15472908. S2CID 1168580.
- Krop I, Parker MT, Bloushtain-Qimron N, Porter D, Gelman R, Sasaki H, Maurer M, Terry MB, Parsons R, Polyak K (November 2005). "HIN-1, an inhibitor of cell growth, invasion, and AKT activation". Cancer Research. 65 (21): 9659–69. doi:10.1158/0008-5472.CAN-05-1663. PMID 16266985.
- Yang Q, Kiernan CM, Tian Y, Salwen HR, Chlenski A, Brumback BA, London WB, Cohn SL (June 2007). "Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome". Clinical Cancer Research. 13 (11): 3191–7. doi:10.1158/1078-0432.CCR-06-2846. PMID 17545522. S2CID 13614534.
- Wu Q, Lothe RA, Ahlquist T, Silins I, Tropé CG, Micci F, Nesland JM, Suo Z, Lind GE (July 2007). "DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets". Molecular Cancer. 6: 45. doi:10.1186/1476-4598-6-45. PMC 1964763. PMID 17623056.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.